GB0014904D0 - Methods of treatment - Google Patents

Methods of treatment

Info

Publication number
GB0014904D0
GB0014904D0 GB0014904A GB0014904A GB0014904D0 GB 0014904 D0 GB0014904 D0 GB 0014904D0 GB 0014904 A GB0014904 A GB 0014904A GB 0014904 A GB0014904 A GB 0014904A GB 0014904 D0 GB0014904 D0 GB 0014904D0
Authority
GB
United Kingdom
Prior art keywords
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0014904A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angiogene Pharmaceuticals Ltd
Original Assignee
Angiogene Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angiogene Pharmaceuticals Ltd filed Critical Angiogene Pharmaceuticals Ltd
Priority to GB0014904A priority Critical patent/GB0014904D0/en
Publication of GB0014904D0 publication Critical patent/GB0014904D0/en
Priority to CN01807663A priority patent/CN1422157A/en
Priority to IL15162701A priority patent/IL151627A0/en
Priority to DK01915495T priority patent/DK1272200T3/en
Priority to SI200130384T priority patent/SI1272200T1/en
Priority to CZ20023231A priority patent/CZ20023231A3/en
Priority to AT01915495T priority patent/ATE298240T1/en
Priority to AU4258601A priority patent/AU4258601A/en
Priority to SK1390-2002A priority patent/SK13902002A3/en
Priority to KR1020027012915A priority patent/KR20020084267A/en
Priority to PT01915495T priority patent/PT1272200E/en
Priority to EEP200200549A priority patent/EE200200549A/en
Priority to JP2001572112A priority patent/JP2003528921A/en
Priority to EP01915495A priority patent/EP1272200B1/en
Priority to HU0300576A priority patent/HUP0300576A3/en
Priority to DE60111622T priority patent/DE60111622T2/en
Priority to BR0109671-0A priority patent/BR0109671A/en
Priority to US10/239,898 priority patent/US20030055024A1/en
Priority to PL01357282A priority patent/PL357282A1/en
Priority to AU2001242586A priority patent/AU2001242586B2/en
Priority to ES01915495T priority patent/ES2243466T3/en
Priority to NZ534190A priority patent/NZ534190A/en
Priority to CA002402078A priority patent/CA2402078A1/en
Priority to PCT/GB2001/001329 priority patent/WO2001074369A1/en
Priority to MXPA02009603A priority patent/MXPA02009603A/en
Priority to IS6555A priority patent/IS6555A/en
Priority to NO20024683A priority patent/NO20024683L/en
Priority to US11/311,618 priority patent/US20070021392A1/en
Ceased legal-status Critical Current

Links

GB0014904A 2000-03-31 2000-06-20 Methods of treatment Ceased GB0014904D0 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
GB0014904A GB0014904D0 (en) 2000-06-20 2000-06-20 Methods of treatment
MXPA02009603A MXPA02009603A (en) 2000-03-31 2001-03-27 Divided dose therapies with vascular damaging activity.
JP2001572112A JP2003528921A (en) 2000-03-31 2001-03-27 Split-dose therapy with vascular damage activity
HU0300576A HUP0300576A3 (en) 2000-03-31 2001-03-27 Divided dose therapies with vascular damaging activity
DK01915495T DK1272200T3 (en) 2000-03-31 2001-03-27 Divided dose therapies with blood vessel damaging activity
SI200130384T SI1272200T1 (en) 2000-03-31 2001-03-27 Divided dose therapies with vascular damaging activity
CZ20023231A CZ20023231A3 (en) 2000-03-31 2001-03-27 Pharmaceutical preparations containing blood vessel-damaging agents
AT01915495T ATE298240T1 (en) 2000-03-31 2001-03-27 SEPARATE DOSE THERAPIES WITH VASCULAR DAMAGED ACTIVITY
AU4258601A AU4258601A (en) 2000-03-31 2001-03-27 Divided dose therapies with vascular damaging activity
SK1390-2002A SK13902002A3 (en) 2000-03-31 2001-03-27 A vascular damaging agent, a kit comprising said agent and use of the agent
KR1020027012915A KR20020084267A (en) 2000-03-31 2001-03-27 Divided dose therapies with vascular damaging activity
PT01915495T PT1272200E (en) 2000-03-31 2001-03-27 THERAPEUTICS IN FRACTIONED DOSES WITH VASCULAR DEGRADATION ACTIVITY
EEP200200549A EE200200549A (en) 2000-03-31 2001-03-27 Split dose therapy with vascular damaging activity
CN01807663A CN1422157A (en) 2000-03-31 2001-03-27 Divided dose therapies with vascular damaging activity
EP01915495A EP1272200B1 (en) 2000-03-31 2001-03-27 Divided dose therapies with vascular damaging activity
IL15162701A IL151627A0 (en) 2000-03-31 2001-03-27 Divided dose therapies with vascular damaging activity
DE60111622T DE60111622T2 (en) 2000-03-31 2001-03-27 ISOLATED DOSE THERAPIES WITH VULNERABLE ACTIVITY
BR0109671-0A BR0109671A (en) 2000-03-31 2001-03-27 Method for producing a vascular damaging effect in a warm-blooded animal, medicament, kit, and uses of a vascular damaging agent and zd6126 or pharmaceutically acceptable salts thereof.
US10/239,898 US20030055024A1 (en) 2000-03-31 2001-03-27 Divided dose therapies with vascular damaging activity
PL01357282A PL357282A1 (en) 2000-03-31 2001-03-27 Divided dose therapies with vascular damaging activity
AU2001242586A AU2001242586B2 (en) 2000-03-31 2001-03-27 Divided dose therapies with vascular damaging activity
ES01915495T ES2243466T3 (en) 2000-03-31 2001-03-27 DIVIDED DOSE THERAPIES WITH VASCULAR HARMFUL ACTIVITY.
NZ534190A NZ534190A (en) 2000-03-31 2001-03-27 Divided dose therapies with vascular damaging activity
CA002402078A CA2402078A1 (en) 2000-03-31 2001-03-27 Divided dose therapies with vascular damaging activity
PCT/GB2001/001329 WO2001074369A1 (en) 2000-03-31 2001-03-27 Divided dose therapies with vascular damaging activity
IS6555A IS6555A (en) 2000-03-31 2002-09-19 Treatment with separate doses that have vasodilatory activity
NO20024683A NO20024683L (en) 2000-03-31 2002-09-30 Divided dose therapies that have vascular damaging activity
US11/311,618 US20070021392A1 (en) 2000-03-31 2005-12-19 Divided dose therapies with vascular damaging activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0014904A GB0014904D0 (en) 2000-06-20 2000-06-20 Methods of treatment

Publications (1)

Publication Number Publication Date
GB0014904D0 true GB0014904D0 (en) 2000-08-09

Family

ID=9893903

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0014904A Ceased GB0014904D0 (en) 2000-03-31 2000-06-20 Methods of treatment

Country Status (1)

Country Link
GB (1) GB0014904D0 (en)

Similar Documents

Publication Publication Date Title
GB0014969D0 (en) Novel method of treatment
GB2393202B (en) Methods of well treatment
IL213240A0 (en) Method of treatment using lighnd-immunogen conjugates
GB0028264D0 (en) Well treatment
GB0007193D0 (en) Treatment of movrmrnt disorders
GB0028269D0 (en) Well treatment
AU5464601A (en) Treatment of scale
PL362855A1 (en) Improved treatment
EG25829A (en) Novel treatment
AU5000001A (en) Treatment of vitiligo
GB0124124D0 (en) Methods of treatment
EP1389105A4 (en) Method of treatment
GB2360453B (en) Treatment of skin conditions
GB0112216D0 (en) Method of treatment
AU9402401A (en) Treatment of cancers
GB0008921D0 (en) Method of treatment
GB0026838D0 (en) Treatment method
GB0118892D0 (en) Method of treatment
GB0130763D0 (en) Treatment methods
EP1303281A4 (en) Methods of treatment
IL161630A0 (en) Methods of treating endometreosis
GB0031321D0 (en) Treatment
GB0013928D0 (en) Methods of treatment
GB0014904D0 (en) Methods of treatment
GB0002762D0 (en) Method of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)